A systematic review of cooling for neuroprotection in neonates with hypoxic ischemic encephalopathy - are we there yet?

Sven M Schulzke, Shripada Rao, Sanjay K Patole, Sven M Schulzke, Shripada Rao, Sanjay K Patole

Abstract

Background: The objective of this study was to systematically review randomized trials assessing therapeutic hypothermia as a treatment for term neonates with hypoxic ischemic encephalopathy.

Methods: The Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, CINAHL databases, reference lists of identified studies, and proceedings of the Pediatric Academic Societies were searched in July 2006. Randomized trials assessing the effect of therapeutic hypothermia by either selective head cooling or whole body cooling in term neonates were eligible for inclusion in the meta-analysis. The primary outcome was death or neurodevelopmental disability at >or= 18 months.

Results: Five trials involving 552 neonates were included in the analysis. Cooling techniques and the definition and severity of neurodevelopmental disability differed between studies. Overall, there is evidence of a significant effect of therapeutic hypothermia on the primary composite outcome of death or disability (RR: 0.78, 95% CI: 0.66, 0.92, NNT: 8, 95% CI: 5, 20) as well as on the single outcomes of mortality (RR: 0.75, 95% CI: 0.59, 0.96) and neurodevelopmental disability at 18 to 22 months (RR: 0.72, 95% CI: 0.53, 0.98). Adverse effects include benign sinus bradycardia (RR: 7.42, 95% CI: 2.52, 21.87) and thrombocytopenia (RR: 1.47, 95% CI: 1.07, 2.03, NNH: 8) without deleterious consequences.

Conclusion: In general, therapeutic hypothermia seems to have a beneficial effect on the outcome of term neonates with moderate to severe hypoxic ischemic encephalopathy. Despite the methodological differences between trials, wide confidence intervals, and the lack of follow-up data beyond the second year of life, the consistency of the results is encouraging. Further research is necessary to minimize the uncertainty regarding efficacy and safety of any specific technique of cooling for any specific population.

Figures

Figure 1
Figure 1
Primary outcome: death or neurodevelopmental disability at 18 to 22 months. Forest plot displays relative risk of death or neurodevelopmental disability at 18 to 22 months for all included studies and separately for selective head cooling and whole body cooling studies. There is a significant benefit of therapeutic hypothermia on the composite outcome of death or disability (RR: 0.78, 95% CI: 0.66, 0.92, NNT: 8, 95% CI: 5, 20). The squares represent the point estimate of treatment effect of each study with a horizontal line extending on either side of the square representing the 95% confidence interval. The diamonds represent the overall and subgroup relative risk estimate of the studies presented in the meta-analysis. The widths of the diamonds represent the 95% confidence interval of the relative risk. The vertical midline of the forest plot corresponding to a relative risk of 1 represents a "no effect" line. Gunn et al 1998 and Gluckman et al 2005 assessed death or severe disability, Shankaran et al 2005 reported on death or moderate or severe disability as described in the results.
Figure 2
Figure 2
Secondary outcome: mortality. Forest plot displays relative risk of death for all included studies and separately for selective head cooling and whole body cooling studies. There is a significant benefit of therapeutic hypothermia on the single outcome of mortality (RR: 0.75, 95% CI: 0.59, 0.96, NNT: 11, 95% CI: 6, 100). The squares represent the point estimate of treatment effect of each study with a horizontal line extending on either side of the square representing the 95% confidence interval. The diamonds represent the overall and subgroup relative risk estimate of the studies presented in the meta-analysis. The widths of the diamonds represent the 95% confidence interval of the relative risk. The vertical midline of the forest plot corresponding to a relative risk of 1 represents a "no effect" line.
Figure 3
Figure 3
Secondary outcome: neurodevelopmental disability at 18 to 22 months. Forest plot displays relative risk of neurodevelopmental disability at 18 to 22 months for all included studies and separately for selective head cooling and whole body cooling studies. There is a significant benefit of therapeutic hypothermia on the single outcome of neurodevelopmental disability at 18 to 22 months (RR: 0.72, 95% CI: 0.53, 0.98, NNT: 9, 95% CI: 5, 100). The squares represent the point estimate of treatment effect of each study with a horizontal line extending on either side of the square representing the 95% confidence interval. The arrowheads indicate a wide confidence interval that is compressed to fit the scale. The diamonds represent the overall and subgroup relative risk estimate of the studies presented in the meta-analysis. The widths of the diamonds represent the 95% confidence interval of the relative risk. The vertical midline of the forest plot corresponding to a relative risk of 1 represents a "no effect" line. Gunn et al 1998 and Gluckman et al 2005 assessed severe disability, Shankaran et al 2005 reported on moderate or severe disability as explained in the results.

References

    1. Robertson CM, Finer NN, Grace MG. School performance of survivors of neonatal encephalopathy associated with birth asphyxia at term. J Pediatr. 1989;114:753–760. doi: 10.1016/S0022-3476(89)80132-5.
    1. Shankaran S, Woldt E, Koepke T, Bedard MP, Nandyal R. Acute neonatal morbidity and long-term central nervous system sequelae of perinatal asphyxia in term infants. Early Hum Dev. 1991;25:135–148. doi: 10.1016/0378-3782(91)90191-5.
    1. Vannucci RC. Current and potentially new management strategies for perinatal hypoxic-ischemic encephalopathy. Pediatrics. 1990;85:961–968.
    1. Jacobs S, Hunt R, Tarnow-Mordi W, Inder T, Davis P. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev. 2003:CD003311.
    1. Cordey R. Resuscitation of the newborn in white asphyxia by means of hypothermia alone or combined with intra-arterial transfusion of oxygenated blood. Bull Fed Soc Gynecol Obstet Lang Fr. 1961;13:507–509.
    1. Westin B. Resuscitation of the newborn. Hypothermic treatment of asphyxia neonatorum. Sven Lakartidn. 1963;60:3608–3620.
    1. Laptook AR, Corbett RJ, Sterett R, Burns DK, Tollefsbol G, Garcia D. Modest hypothermia provides partial neuroprotection for ischemic neonatal brain. Pediatr Res. 1994;35:436–442. doi: 10.1203/00006450-199404000-00011.
    1. Thoresen M, Penrice J, Lorek A, Cady EB, Wylezinska M, Kirkbride V, Cooper CE, Brown GC, Edwards AD, Wyatt JS, Reynolds EO. Mild hypothermia after severe transient hypoxia-ischemia ameliorates delayed cerebral energy failure in the newborn piglet. Pediatr Res. 1995;37:667–670. doi: 10.1203/00006450-199505000-00019.
    1. Gunn AJ, Gunn TR, de Haan HH, Williams CE, Gluckman PD. Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J Clin Invest. 1997;99:248–256.
    1. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet. 2005;365:663–670.
    1. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, Fanaroff AA, Poole WK, Wright LL, Higgins RD, Finer NN, Carlo WA, Duara S, Oh W, Cotten CM, Stevenson DK, Stoll BJ, Lemons JA, Guillet R, Jobe AH. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. New Engl J Med. 2005;353:1574–1584. doi: 10.1056/NEJMcps050929.
    1. Eicher DJ, Wagner CL, Katikaneni LP, Hulsey TC, Bass WT, Kaufman DA, Horgan MJ, Languani S, Bhatia JJ, Givelichian LM, Sankaran K, Yager JY. Moderate hypothermia in neonatal encephalopathy: efficacy outcomes. Pediatr Neurol. 2005;32:11–17. doi: 10.1016/j.pediatrneurol.2004.06.014.
    1. Barrowman NJ, Fang M, Sampson M, Moher D. Identifying null meta-analyses that are ripe for updating. BMC Med Res Methodol. 2003;3:13. doi: 10.1186/1471-2288-3-13.
    1. Davis PG. Cochrane reviews in neonatology: past, present and future. Semin Fetal Neonatal Med. 2006;11:111–116. doi: 10.1016/j.siny.2005.11.004.
    1. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol. 1976;33:696–705.
    1. Finer NN, Robertson CM, Richards RT, Pinnell LE, Peters KL. Hypoxic-ischemic encephalopathy in term neonates: perinatal factors and outcome. J Pediatr. 1981;98:112–117. doi: 10.1016/S0022-3476(81)80555-0.
    1. Palisano R, Rosenbaum P, Walter S, Russel D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39:214–223.
    1. Griffiths R. The Abilities of Young Children: A Comprehensive System of Mental Measurement for the First Eight Years of Life. High Wycombe, UK: The Test Agency; 1970.
    1. Bayley N. Bayley Scales of Infant Development-II. San Antonio, Texas: Psychological Corporation; 1993.
    1. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomsied controlled trials: the Quorom Statement. Lancet. 1999;354:1896–1900. doi: 10.1016/S0140-6736(99)04149-5.
    1. Gunn AJ, Gluckman PD, Gunn TR. Selective head cooling in newborn infants after perinatal asphyxia: a safety study. Pediatrics. 1998;102:885–892. doi: 10.1542/peds.102.4.885.
    1. Battin MR, Dezoete JA, Gunn TR, Gluckman PD, Gunn AJ. Neurodevelopmental outcome of infants treated with head cooling and mild hypothermia after perinatal asphyxia. Pediatrics. 2001;107:480–484. doi: 10.1542/peds.107.3.480.
    1. Battin MR, Penrice J, Gunn TR, Gunn AJ. Treatment of term infants with head cooling and mild systemic hypothermia (35.0 degrees C and 34.5 degrees C) after perinatal asphyxia. Pediatrics. 2003;111:244–251. doi: 10.1542/peds.111.2.244.
    1. Shankaran S, Laptook A, Wright LL, Ehrenkranz RA, Donovan EF, Fanaroff AA, Stark AR, Tyson JE, Poole K, Carlo WA, Lemons JA, Oh W, Stoll BJ, Papile LA, Bauer CR, Stevenson DK, Korones SB, McDonald S. Whole-body hypothermia for neonatal encephalopathy: animal observations as a basis for a randomized, controlled pilot study in term infants. Pediatrics. 2002;110:377–385. doi: 10.1542/peds.110.2.377.
    1. Eicher DJ, Wagner CL, Katikaneni LP, Hulsey TC, Bass WT, Kaufman DA, Horgan MJ, Languani S, Bhatia JJ, Givelichian LM, Sankaran K, Yager JY. Moderate hypothermia in neonatal encephalopathy: safety outcomes. Pediatr Neurol. 2005;32:18–24. doi: 10.1016/j.pediatrneurol.2004.06.015.
    1. Akisu M, Huseyinov A, Yalaz M, Cetin H, Kultursay N. Selective head cooling with hypothermia suppresses the generation of platelet-activating factor in cerebrospinal fluid of newborn infants with perinatal asphyxia. Prostaglandins Leukot Essent Fatty Acids. 2003;69:45–50. doi: 10.1016/S0952-3278(03)00055-3.
    1. Zhou WH, Shao XM, Zhang XD, Chen C, Huang GY. Effects of hypothermia on cardiac function in neonates with asphyxia. Zhonghua Er Ke Za Zhi. 2003;41:460–462.
    1. Shao X, Zhou W, Cheng G, Wang L, Cao Y, Zhang X. Head cooling in neonatal hypoxic-ischaemic encephalopathy – multicenter randomised trial from China. Hot Topics in Neonatology. 2005.
    1. Lin ZL, Yu HM, Lin J, Chen SQ, Liang ZQ, Zhang ZY. Mild hypothermia via selective head cooling as neuroprotective therapy in term neonates with perinatal asphyxia: an experience from a single neonatal intensive care unit. J Perinatol. 2006;26:180–184. doi: 10.1038/sj.jp.7211412.
    1. Freemantle N, Calvert M, Wood J, Eastaugh J, Griffin C. Composite outcomes in randomized trials. Greater precision but with greater uncertainty? JAMA. 2003;289:2554–2559. doi: 10.1001/jama.289.19.2554.
    1. Wyatt JS, Gluckman PD, Liu PY, Azzopardi D, Ballard RA, Edwards AD, Ferriero DM, Polin RA, Robertson CM, Thoresen M, Whitelaw A, Gunn AJ, on behalf of the CoolCap study group Determinants of outcomes after head cooling for neonatal encephalopathy. Pediatrics. 2007;119:912–921. doi: 10.1542/peds.2006-2839.
    1. Ziino A. Palliation bias is being overlooked in neonatal hypothermia trials. Arch Dis Child Fetal Neonatal Ed. 2006;91:127–131. doi: 10.1136/adc.2005.071787.
    1. Lucey JF. Plan and think ahead about brain cooling – it will have a major impact on your NICU in ten years. Hot Topics in Neonatology. 2005. Oral lecture.
    1. Blackmon LR, Stark AR. Hypothermia: a neuroprotective therapy for neonatal hypoxic-ischemic encephalopathy. Pediatrics. 2006;117:942–948. doi: 10.1542/peds.2005-2950.
    1. Edwards AD, Azzopardi DV. Therapeutic hypothermia following perinatal asphyxia. Arch Dis Child Fetal Neonatal Ed. 2006;91:F127–31. doi: 10.1136/adc.2005.071787.
    1. Papile LA. Systemic hypothermia – a "cool" therapy for neonatal hypoxic-ischemic encephalopathy. New Engl J Med. 2005;353:1619–1620. doi: 10.1056/NEJMe058199.
    1. Gunn AJ. Cerebral hypothermia for prevention of brain injury following perinatal asphyxia. Curr Opin Pediatr. 2000;12:111–15. doi: 10.1097/00008480-200004000-00004.
    1. TOBY: a study of treatment for perinatal asphyxia
    1. Perinatal trials report PTO367 ICE: Infant Cooling Evaluation Trial
    1. Induced systemic hypothermia in asphyxiated newborn infants: a randomized, controlled, multicenter study
    1. Silverman WA. Controlled trials and medical ethics. Lancet. 1979;313:160–161. doi: 10.1016/S0140-6736(79)90555-5.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir